Raul Aguilar Schall

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +16

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 389 citations

Medicine, Pathology, Pharmacotherapy +17

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell et al. · Gastroenterology · 2018 · 372 citations

Medicine, Internal Medicine, Pharmacology +13

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Naoky Tsai, Joerg Petersen, Robert Flisiak et al. · Digestive Diseases and Sciences · 2014 · 298 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Prenatal and Postnatal Bisphenol A Exposure and Body Mass Index in Childhood in the CHAMACOS Cohort

Kim G. Harley, Raul Aguilar Schall, Jonathan Chevrier et al. · Environmental Health Perspectives · 2013 · 253 citations · Full text

Pharmacy, Child Health, Toxicology +17